Ms. Anu Acharya
Founder & CEO, Ocimum Biosolutions

Ms. Acharya is the founder & CEO of Ocimum Biosolutions, a global genomics outsourcing partner for discovery, development and diagnostics. The company was founded in the year 2000 and has completed 3 international acquisitions, Gene Logic’s Genomics Division from Maryland, USA, in the year 2007, Isogen Life Sciences from The Netherlands in 2006, and the GD business of MWG Biotech of Germany in 2005. Ocimum today has over 2000 customers worldwide and operates under the main business units of Lab, Sample and Data Management; BioResearch Design and Execution; Data Analytics and Insights; and Integrated Solutions. Ocimum has raised capital from Kubera Cross Border Fund (KUBC) for an equity investment of up to US$17 million (including the pro rata investment by affiliates of Kubera Partners, LLC, the Investment Manager of KUBC). Ocimum was previously financed by the International Finance Corporation (IFC), the private Equity arm of the World Bank.

Prior to founding Ocimum Biosolutions, Ms. Acharya has had rich experience in the Telecom, IT and entrepreneurship arenas. She worked for a startup in the telecommunications space called Mantiss Information and a consulting firm called SEI Information where she helped create a social networking site for entrepreneurs. Her experience is backed by education at premier institutions like the Indian Institute of Technology at Kharagpur, India (IIT) and University of Illinois where she has two Post Graduate degrees in Physics and MIS.

She is a regular in technology forums and round tables and one of the well known first generation entrepreneurs in the Indian life sciences space. She was named by Red Herring Magazine to the list of "25 Tech Titans under 35" in 2006. Ocimum has received several awards including "Fastest Growing Life Sciences Company in India", Red Herring Asia 100, "IT Innovation Award" by NASSCOM and has been named to the Deloitte list of Fastest Growing companies in Asia, four years in a row. She has been named Biospectrum “Entrepreneur of the Year” for 2008 and also has been awarded the Astia Life Science Innovators Award in the same year.

|

Mr. Subash Lingareddy
Founder, President & CFO, Ocimum Biosolutions

Mr. Subash Lingareddy is a Financial Professional and a CFA charter holder with over six years of experience working in several roles from an equity analyst to a financial risk manager, before joining Ocimum. He has an MBA from the University of Illinois at Urbana Champaign with a concentration in Corporate Finance. He has a MS in Financial Mathematics from the University of Chicago specializing in risk management. He has a Bachelors degree in Physics from the Indian Institute of Technology at Kharagpur.

|

Dr. Cy Cabradilla
VP, Global BioResearch Operations, Ocimum Biosolutions

Dr. Cabradilla is Vice President, Global Bioresearch operations. He is based out of the Gaithersburg office. Prior to joining Ocimum Biosolutions, Dr. Cabradilla was the COO of BioSearch. His experience includes 22 years of successful project management and product development with over 130 new products in 5 years. His experience span companies like Eurogentec, Epoch BioSciences and other Biotech companies. Dr. Cabradilla is an accomplished and creative leader in operation, strategic planning, business development, project management, and product development. He has several peer reviewed publications to his credit. He holds a PhD from University of California, Davis.

Mr. Vinay Kumar
VP, BioResearch, India, Ocimum Biosolutions

Vice President at Ocimum Biosolutions, Vinay is responsible for on-time and quality delivery of Bioresearch services offered from Ocimum’s Hyderabad and IJsselstein labs. He also assists in corporate strategy, mergers/acquisitions/divestitures, collaborations and partnerships.

Vinay has over 10 years of experience in the high-technology industries in various functions – sales, operations, consulting; as well as extensive entrepreneurial experience. Vinay holds an MBA in Marketing and Technology from the Indian School of Business, Hyderabad, and a Bachelors in Technology degree from the Indian Institute of Technology, Delhi.

Mr. Tom Thompson
VP, BioIT Sales, Ocimum Biosolutions

Mr. Thompson is the Vice President of Sales of the BioIT Division of Ocimum Biosolutions. He joined Ocimum through the Gene Logic Genomics Division acquisition in 2007. During his nine years at Gene Logic he has been a key member sales management and direct sale teams that built the gene expression database business. Prior to Gene Logic, Mr. Thompson held sales, marketing, and sales/marketing management roles during thirteen years of service at GE Healthcare (formerly Amersham Pharmacia Biotech). Mr. Thompson holds a M.S. in Microbiology and Immunology from Indiana University and a B.A. in Biology from Wabash College.

Dr. Ron Hencin
VP, Global BioResearch Sales, Ocimum Biosolutions

Dr. Hencin is the Vice President of BioResearch Sales operations. Dr. Hencin heads the US genomics services sales efforts and has a successful track record in direct sales of genomic and bioinformatic products and services to major pharmaceutical and biotech corporations. Prior to joining Gene Logic, Dr. Hencin was the co-founder of Level Five Research and worked at many other hi-tech companies such as Planning Research Corporation, Information Builders, and Inso. He has both extensive entrepreneurial experience and sales experience in the genomics services space and has been instrumental in building the services business at Gene Logic. Dr. Hencin possesses a broad technology background ranging from genomic services to IT. He holds a PhD in Microbiology from University of Florida at Gainesville and a B.S. in Biology from Yale University.

Dr. Howard Rosenberg
Executive Director, LIMS, Ocimum Biosolutions

Dr. Howard Rosenberg is the Executive Director – LIMS at Ocimum Biosolutions. Howard has extensive experience in scientific software solution development as well as enterprise software and services sales and marketing. With over 20 years of experience addressing the needs of the pharmaceutical and biotech industries for software solutions across both R&D and QA, Howard also has broad domain knowledge that enables him to provide high value to our clients. Howard holds a Ph.D. from Duke University in Analytical Chemistry as well as a Bachelors of Arts (Cum Laude) with Honors in Chemistry from Brandeis University.